PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 124 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $211,500 | -78.5% | 50,000 | -88.0% | 0.21% | -79.3% |
| Q3 2022 | $984,000 | -19.1% | 415,000 | +3.8% | 1.01% | +185.3% |
| Q4 2021 | $1,216,000 | +16.8% | 400,000 | +169.4% | 0.35% | +33.6% |
| Q3 2021 | $1,041,000 | +183.7% | 148,500 | +271.2% | 0.26% | +165.0% |
| Q2 2021 | $367,000 | +89.2% | 40,000 | +100.0% | 0.10% | +53.8% |
| Q1 2021 | $194,000 | +100.0% | 20,000 | +110.5% | 0.06% | +62.5% |
| Q4 2020 | $97,000 | – | 9,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |